Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'design drug'
design drug published presentations and documents on DocSlides.
Why drug cocktails are more effective than single-drug therapies, and how to design them
by lindy-dunigan
Harvard Life Sciences Outreach. November 9, 2017....
Lungs alveolar targeted drug delivery:
by pamella-moone
Formulation and Evaluation of Isoniazid Mucoadhes...
DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
by olivia-moreira
Isaguliants. Maria. Department of Microbiology, ...
Drug Testing, Design, Marketing
by kittie-lecroy
Drug Discovery . Ancient Sources. Many drugs stil...
Pharmaceultical dosage form design and drug delivery systems
by emmy
Lecturer Dr . Athmar. . Dhahir. . Habeeb. PhD in...
Targeting SARS-COV2 Main Protease Using HTVS and Simulation Analysis: A Drug Repurposing Approach a
by singh
Virupaksha. A. Bastikar. 1. ; . Pramodkumar. Gup...
Designing “girl-friendly” drug shops in Tanzania:
by trinity
An application of human-centered design to facilit...
S eminar on
by min-jolicoeur
CLINICAL TRIALS. Presented by. Y.SRUTHI. M.Pharma...
Phases in Drug D evelopment
by conchita-marotz
I: . Pre-clinical studies. Kausar Ahmad. D...
Perspectives of Antifungal Drug Discovery
by mia
Josef . Jampílek. Department of Pharmaceutical Ch...
Design considerations for drug development in the era of immuno-oncology
by isabella
Elizabeth Garrett-Mayer, PhD. Director, Division o...
Framing Research Research Workforce Framing Design
by oakley
Alison K. Hall, PhD. Associate Dean, Research Work...
STUDY DESIGN AND EFFICIENCY
by alida-meadow
MfD. . – Wednesday 23rd . January . 2013. Ioan...
QBD Quality by Design
by krew593
Overview. Elements of . QbD. program. Tools. QUAL...
STUDY DESIGN AND EFFICIENCY
by alexa-scheidler
MfD. . – Wednesday 23rd . January . 2013. Ioan...
Dr G P S Raghava, Head Bioinformatics Centre
by conchita-marotz
Institute of Microbial Technology, Chandigarh, In...
Dosage Form Design: Biopharmaceutical and Pharmacokinetic Considerations
by wayne461
Chapter 5. Dr. Shaimaa. Biopharmaceutics. Is . the...
ICH Purpose, participants, process of harmonization, Brief overview of QSEM, with special emphasis
by white
INTERNATIONAL COUNCIL FOR HARMONIZATION. Q1B- . Ph...
A seminar on Prodrugs BY
by eddey
K.SUNITHA. . M.Pharm....
Dosage Form Design Lecture
by yvonne
5 and 6 . Dr. . . Athmar. . Dhahir. Habeeb. PhD ...
Official address
by delilah
Domenico Scarlattilaan 6 1083 HS Amsterdam The Ne...
Dosage Form Design Chapter 1
by scarlett
Dr. . . Athmar. . Dhahir. Habeeb. PhD in Industr...
Dosage Form Design Lecture 1 and 2
by norah
13/2/2018. Dr. . Athmar. . Dhahir. Habeeb. PhD i...
Dosage Form Design Lecture 1
by rosemary
17/2/2019. Dr. . Athmar. . Dhahir. Habeeb. PhD i...
Dosage Form Design Lecture 2
by faustina-dinatale
19/2/2019. Dr. . Athmar. . Dhahir. Habeeb. PhD ...
Pastillation Technology Based Design & Development of Oral Modified Release Multiparticulate Dr
by trish-goza
Presented by:. Prof. B. Mishra. Professor & F...
Design of Clinical Trials
by faustina-dinatale
Robert Temple, M.D.. Food and Drug Administration...
Targeted Drug Delivery to Atherosclerotic Plaques
by marina-yarberry
“Plaque Man” – QGEM 2009. Atherosclerosis: ...
FUNDAMENTALS OF MODIFIED RELEASE FORMULATIONS
by test
Dr. . Basavraj. K. . Nanjwade. . M. Pharm., P...
Do drug
by alida-meadow
per se . laws work?. A critique of . “Per Se Dr...
Modeling and Simulation
by lois-ondreau
beyond PK/PD. CPTR Workshop October 2 – 4, 2012...
Pastillation Technology Based Design & Development of O
by danika-pritchard
Presented by:. Prof. B. Mishra. Professor & F...
OMICS
by phoebe-click
International . welcomes submissions that are ori...
Pastillation Technology Based Design & Development of O
by conchita-marotz
Presented by:. Prof. B. Mishra. Professor & F...
Clinical Trial Protocol & Amendments
by liane-varnes
William Petros, PharmD, FCCP. Professor, Schools ...
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
OMICS International welcomes submissions that are original and technically so as to serve both th
by briana-ranney
OMICS Journals are poised in excellence by publi...
Adapting for Success: The Genesis of Adaptive Designs
by alida-meadow
Andy Grieve. SVP Clinical Trials Methodology, . I...
ACTHD ATOD Commissioning
by emily
Processes, contracts and where to from here. ACT H...
Research Policy on Case-control and Cohort Study Design in Pharmaceutical Care
by CutiePatootie
Yousef Ahmed . Alomi. , Amal Hassan Al-Najjar, . M...
Load More...